Drug
Suvorexant clinical trials
Also written Belsomra, MK-4305 and SCH 900433.
- studies test it
- 63
- open now
- 11
- in phase 3
- 7
- first study started
- 2008
Keep track of what changes. Save the suvorexant studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
63 studies that test it; most in 2019 (12)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2015 | 1 |
| 2016 | 8 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 12 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 7
- Phase 2
- 20
- Phase 3
- 7
- Phase 4
- 26
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 51
Merck Sharp & Dohme LLC (12) · Johns Hopkins University (4) · Massachusetts General Hospital (4) · The University of Texas Health Science Center, Houston (3) · University of California, San Francisco (2) · Brigham and Women's Hospital (2) · Ohio State University (2) · Howard University (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses suvorexant is read from its arms, and is right about nine times in ten.
Testing it · 63
- Suvorexant for Alcohol Use Disorder (AUD): Neural MechanismsRecruitingPhase 1/2National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT06484075Written as Suvorexant
- Suvorexant for Treatment of AUD and PTSDRecruitingPhase 2Pharmacotherapies for Alcohol and Substance Use Disorders AllianceNCT06679062Written as Suvorexant
- Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related DrinkingRecruitingPhase 2Ohio State UniversityNCT07214207Written as Suvorexant 10 mg
- A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06655883Written as Suvorexant
- Sleep Trial to Prevent Alzheimer's DiseaseRecruitingPhase 2University of MinnesotaNCT04629547Written as Suvorexant 20 mg
- Suvorexant 3 - PE-PCNot yet recruitingPhase 4Northern California Institute of Research and EducationNCT07686731Written as Suvorexant
- Suvorexant and AlcoholRecruitingEarly Phase 1William StoopsNCT06326684Written as Suvorexant
- The Effects of Orexin Antagonism on Fear Extinction in PTSDNot yet recruitingPhase 4VA Office of Research and DevelopmentNCT06788522Written as Suvorexant
- Trial of Suvorexant for Sleep in Children With AutismRecruitingPhase 2Stanford UniversityNCT05546554Written as Suvorexant
- Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical TrialRecruitingPhase 2Marianne GoodmanNCT06854224Written as Suvorexant (dual orexin receptor antagonist)
- Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic StressRecruitingPhase 4VA Office of Research and DevelopmentNCT03642028Written as Suvorexant
- Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use DisorderCompletedPhase 2Johns Hopkins UniversityNCT04287062Written as Suvorexant
- Targeting Orexin to Treat Nicotine DependenceCompletedPhase 1Mclean HospitalNCT03999099Written as Suvorexant 20 mg
- Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)CompletedPhase 4University of California, San FranciscoNCT04014387Written as Suvorexant
- Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer SurvivorsTerminatedPhase 4Medical University of South CarolinaNCT06162663Written as Suvorexant Tablets
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use FentanylCompletedPhase 2Johns Hopkins UniversityNCT05145764Written as Suvorexant
- Efficacy of Suvorexant on Post-operative Sleep DisturbanceCompletedPhase 4Columbia UniversityNCT05823844Written as Suvorexant
- Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study)CompletedPhase 4Massachusetts General HospitalNCT06584942Written as Suvorexant
- Treating Insomnia and Improving Metabolic Health in Midlife Women With InsomniaCompletedPhase 4Brigham and Women's HospitalNCT05593653Written as Suvorexant
- REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With SuvorexantCompletedPhase 2Duke UniversityNCT05733286Written as Suvorexant 20 mg
See all 63 studies that test suvorexant →
Given in every arm · 4 — suvorexant is usual care beside what is tested
- Orexin s Role in the Neurobiology of Substance Use DisorderRecruitingNot applicableNational Institute on Drug Abuse (NIDA)NCT05630781Written as Belsomra
- Measuring Acute Drug Demand in HumansRecruitingEarly Phase 1University of Maryland, BaltimoreNCT05829655Written as Suvorexant (20mg/day)
- A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and ZolpidemCompletedPhase 1Janssen Research & Development, LLCNCT05106153Written as Suvorexant
- A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative UsersCompletedPhase 1Eisai Inc.NCT03158025Written as Suvorexant tablets, over-encapsulated
As the comparator · 1 — what is tested is compared with suvorexant
Codes
What other systems call suvorexant · ClinicalTrials.gg INT005689
- MeSH (NLM) C551624suvorexantConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 081L192FO9SUVOREXANTConfirmed FDA, NLM, Wikidata
- RxNorm 1547099Confirmed FDA, Wikidata
- Wikidata Q7650517suvorexantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171858SuvorexantOne source FDA
- DrugBank DB09034One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C551624 | suvorexant | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 081L192FO9 | SUVOREXANT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1547099 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7650517 | suvorexant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171858 | Suvorexant | One source FDA |
| DrugBank | DB09034 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.